Trust Signals
Standards: All claims are graded by evidence type. No affiliate relationships influence compound ratings.
Last updated: May 29, 2026.
Legal notice: Both compounds are Schedule III controlled substances in the United States. This page is for educational purposes only and does not constitute medical advice or encourage illegal activity.
Key Takeaways
- Dbol (methandrostenolone) aromatizes to estrogen; Tbol (chlorodehydromethyltestosterone) does not, because the 4-chloro substitution blocks aromatase, making their side-effect profiles meaningfully different despite structural similarity.
- Tbol's long-chain cysteine metabolite was detectable for many months in WADA anti-doping research, making it a far greater detection risk than its short half-life would suggest.
- Both compounds are 17-alpha-alkylated and hepatotoxic. East German doping records document liver enzyme elevations and long-term hepatic changes in Tbol users; this risk is not lower than Dbol's at equivalent doses.
- Dbol has a longer history in published clinical trials (osteoporosis, wasting disease studies from the 1960s to 1980s). Most Tbol human data comes from East German state records and anti-doping forensics, not controlled trials.
- Neither compound has a currently approved medical indication in the United States. Both suppress the HPG axis and require post-cycle management if endogenous testosterone recovery is a goal.
Direct Answer: Tbol vs Dbol at a Glance
Tbol and Dbol are structurally related oral anabolics with meaningfully different profiles. Dbol produces faster, larger strength and mass gains but adds substantial water retention and estrogenic side effects because it aromatizes. Tbol produces slower, leaner gains with no aromatization, but is not a free ride: it is equally hepatotoxic, suppresses testosterone, and carries a surprisingly long detection window.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of Contents
- How are Tbol and Dbol structurally different?
- What do the mechanisms actually tell us, with specific numbers?
- Evidence ledger: what claims are well-supported?
- Which produces better gains, Tbol or Dbol?
- What are the real side effects of each?
- What most comparison pages get wrong
- Honest head-to-head table
- Detection times and anti-doping reality
- Operational and label literacy: reading what you buy
- FAQ
- Sources
- Footer Disclaimers
How Are Tbol and Dbol Structurally Different?
Dianabol is methandrostenolone: testosterone with a 17-alpha-methyl group (enabling oral activity) and an additional 1,2 double bond in the A-ring. Turinabol is chlorodehydromethyltestosterone, which is essentially Dbol with an added 4-chloro substitution on the A-ring. That single chlorine atom has large downstream consequences. The 4-chloro group sterically and electronically prevents aromatase from converting the steroid to an estrogen. It also slightly reduces androgenic potency relative to anabolic potency, shifting the anabolic-to-androgenic ratio compared to Dbol. Both retain the 17-alpha-methyl group, so both are orally bioavailable and both impose hepatic metabolic stress through that same mechanism.
What Do the Mechanisms Actually Tell Us, With Specific Numbers?
Dbol binds the androgen receptor with roughly 94% of the relative binding affinity of testosterone in in-vitro assays (Saartok et al., 1984, a well-cited receptor binding study). It also binds the progesterone receptor weakly and binds sex-hormone-binding globulin (SHBG) with high affinity, displacing other androgens and effectively raising free androgen levels beyond its own direct activity. Its reported anabolic-to-androgenic ratio is approximately 90-210 to 40-60 (referenced ranges vary by source and assay method).
Tbol's anabolic-to-androgenic ratio is reported in pharmacology references as roughly 100 anabolic to 50 androgenic (Kochakian, 1976 reference range). It does not bind estrogen receptors and does not convert to estrogen. It also binds SHBG, which partially explains why athletes used it in combination with testosterone esters to increase free testosterone availability.
What the mechanism does NOT prove: In-vitro receptor binding ratios do not translate cleanly to real-world muscle gain magnitude or safety profiles. A higher anabolic-to-androgenic ratio on paper does not mean proportionally more muscle or fewer side effects in a human, because hepatic first-pass, individual metabolism, dose, and duration all dominate real-world outcomes.
Evidence Ledger: What Claims Are Well-Supported?
| Claim | Best Evidence Type | Effect Direction | Confidence |
|---|---|---|---|
| Dbol increases lean mass and strength | Human RCTs and controlled trials (1960s-80s clinical use) | Positive, moderate-to-large effect at typical doses | High (for pharmacological effect; long-term safety data limited) |
| Dbol aromatizes to estrogen and causes water retention | Human clinical observation, mechanistic (aromatase conversion established) | Confirmed | High |
| Tbol does not aromatize | Mechanistic (4-chloro aromatase blockade), supported by absence of estrogenic findings in East German records | Confirmed | High |
| Tbol produces lean, keepable gains with less water retention than Dbol | Historical athlete records, anecdotal cohort; no head-to-head RCT | Positive but magnitude versus Dbol unquantified in controlled data | Low to Moderate |
| Both compounds are hepatotoxic via 17-AA mechanism | Human clinical and biochemical data (enzyme elevations documented) | Risk confirmed for both | High |
| Tbol causes long-duration metabolite detection | WADA-commissioned anti-doping analytical research (Thevis, Schanzer groups) | Confirmed, months-level detection possible | High |
| Both suppress HPG axis / endogenous testosterone | Mechanistic (negative feedback) and clinical observation | Confirmed | High |
| Tbol is safer than Dbol overall | No controlled comparative trial; inference from aromatization difference only | Unclear; aromatization risk lower, hepatic and HPG risk similar | Very Low |
Which Produces Better Gains, Tbol or Dbol?
Dbol produces faster and numerically larger increases in scale weight and short-term strength, largely because much of the early gain is water held intracellularly and extracellularly in response to estrogenic activity. Athletes using Dbol at typical recreational doses often report several kilograms of weight gain in the first two weeks, a significant portion of which reverses when the drug clears and estrogen drops. Tbol gains arrive more slowly and are composed of a higher proportion of lean tissue relative to water, but peak anabolic output is lower. There is no controlled head-to-head human trial comparing the two. The practical distinction is: Dbol is chosen when rapid mass accumulation is the goal; Tbol is chosen when appearance quality or detection avoidance matters more.
What Are the Real Side Effects of Each?
Shared by both: HPG axis suppression, hepatotoxicity (elevated ALT/AST, risk of peliosis hepatis with prolonged use), dyslipidemia (HDL reduction is documented for both oral 17-AA steroids), androgenic effects including acne, accelerated male pattern baldness in genetically susceptible individuals, and virilization in females.
Dbol-specific: Gynecomastia from aromatization, significant water retention and associated transient hypertension, progesterone receptor activity at higher doses.
Tbol-specific: Absence of aromatization-related sides is the main differentiator. However, East German records document that female athletes given Tbol experienced virilization (voice deepening, clitoral enlargement, menstrual disruption) even at lower doses. The 4-chloro group does not eliminate androgenicity.
What Most Comparison Pages Get Wrong
1. Calling Tbol the "safe Dbol." The framing that Tbol is simply a milder, safer version omits that its hepatotoxic mechanism is identical, its HPG suppression is real, its androgenic side effects at higher doses are significant, and its detection window is actually longer than Dbol's for athletes subject to testing.
2. Underestimating the Tbol detection problem. Most articles cite Tbol's half-life (roughly 16 hours) and call it a short-detection compound. This was the assumption East German athletes operated under. WADA-affiliated researchers (Thevis and colleagues at the German Sport University Cologne) identified a long-chain cysteine conjugate metabolite that persists far beyond the parent compound's clearance, demonstrably for many months. Athletes have been retroactively sanctioned years after competing based on re-analysis of stored samples for this metabolite.
3. Ignoring sourcing and purity reality. Neither compound has a currently manufactured pharmaceutical product approved in the US. What is sold in gray-market or underground laboratory contexts has no guaranteed purity, dose accuracy, or sterility standard. Independent third-party testing of underground oral steroids has repeatedly found underdosing, overdosing, or contamination with other compounds. A tablet labeled "Tbol 10 mg" has no regulatory backstop on that claim.
4. Omitting the SHBG displacement effect of Dbol. Dbol's high SHBG affinity means it raises free testosterone (and free other androgens) independently of its direct receptor binding. This is part of why Dbol's practical anabolic effect feels larger than its receptor affinity alone predicts, and why it was historically combined with testosterone esters by clinical prescribers.
Honest Head-to-Head Table
| Parameter | Tbol (Chlorodehydromethyltestosterone) | Dbol (Methandrostenolone) | Winner / Honest Call |
|---|---|---|---|
| Speed of mass gain | Slow, lean | Fast, includes water | Dbol (if raw scale weight is goal) |
| Water retention | Minimal (no aromatization) | Substantial | Tbol |
| Gynecomastia risk | Low (no aromatization) | Moderate to high without AI | Tbol |
| Hepatotoxicity | Real, documented | Real, documented | Tie (both 17-AA, comparable risk) |
| HPG axis suppression | Yes | Yes | Tie |
| Androgenic side effects | Moderate | Moderate to high | Tbol (marginal) |
| Detection window | Very long (metabolite, months) | Weeks by standard urine testing | Dbol (shorter detection) |
| Human clinical trial data | Sparse; mostly anti-doping forensics | More extensive; clinical use in 1960s-80s | Dbol |
| US legal status | Schedule III controlled substance | Schedule III controlled substance | Tie (both illegal without Rx) |
| Pharmaceutical availability | Not currently approved/manufactured in US | Not currently approved/manufactured in US | Tie |
Detection Times and Anti-Doping Reality
Dbol's primary urinary metabolites (principally 17-epimethandrostenolone) are detectable by standard immunoassay and GC-MS methods for roughly two to four weeks after cessation at typical doses, though this varies with dose and individual metabolism. Higher doses extend this window.
Tbol's detection story is more complicated and has caught many athletes off guard. The parent compound and its straightforward metabolites clear relatively quickly given the roughly 16-hour half-life. However, WADA-funded research (Thevis group, published in peer-reviewed anti-doping journals) identified that Tbol forms a long-lived cysteine-conjugated metabolite. Stored urine samples from major competitions have been re-analyzed using this marker and produced positive findings many months to over a year after the samples were collected. Athletes who believed they were safely past detection have received retroactive bans under WADA's 10-year sample storage rule. This is the single most practically important and least-reported fact in Tbol discussions.
Operational and Label Literacy: Reading What You Buy
What a legitimate pharmaceutical product looks like (historical reference only): Genuine pharmaceutical Dbol was produced by Ciba as Dianabol. Tbol was manufactured for East German state use and never widely commercialized under a common trade name for the public. There is currently no legitimate pharmaceutical manufacturer producing either compound for US-approved medical use.
Underground lab reality check: If you encounter either compound through gray or black markets, independent verification is the only meaningful quality check. What to look for:
- A certificate of analysis (COA) from a named, independently verifiable third-party laboratory, not one printed by the seller.
- HPLC or LC-MS/MS quantification, not just identity confirmation. Identity testing tells you the compound is present; quantitative testing tells you whether 10 mg is actually 10 mg.
- Look for heavy metal and solvent residual testing if capsules or tablets are being assessed.
Degradation and stability: Both compounds are relatively stable small molecules in tablet or capsule form when stored away from heat, light, and humidity. There is no well-characterized rapid ambient degradation pathway for either at standard storage conditions, unlike peptide compounds that denature at room temperature. However, binders and fillers in underground tablets are uncontrolled, and pressed tablet integrity can vary.
What a degraded or counterfeit product looks like: Unusual color variation across tablets in a batch, inconsistent tablet weight or size, unexpected taste, and absence of the expected physiological response at the stated dose are all practical red flags. None of these are definitive without analytical testing.
Dosing context from historical records: East German programs used Tbol in female athletes at approximately 20-30 mg per day and higher doses in male athletes, typically cycling it over weeks to months. Dbol clinical use in the 1960s through 1980s was typically 5-25 mg per day for medical indications. Recreational bodybuilding doses for Dbol commonly exceed clinical ranges. Neither compound has a current approved dosing protocol, and any dose carries the hepatotoxic and HPG-suppressive risks described above.
FAQ
What is the main difference between Tbol and Dbol?
Dianabol (methandrostenolone) produces faster, larger mass and strength gains but causes significant water retention and aromatizes to estrogen. Turinabol (chlorodehydromethyltestosterone) produces slower, leaner gains with no aromatization and less water retention, at the cost of lower peak anabolic potency.
Does Tbol aromatize to estrogen?
No. The 4-chloro substitution on Turinabol's A-ring blocks aromatase activity, so it does not convert to estrogen. This eliminates gynecomastia risk from aromatization, though androgenic effects and SHBG suppression still occur.
Which is more liver toxic, Tbol or Dbol?
Both are 17-alpha-alkylated oral steroids and both are hepatotoxic. Clinical data from East German doping programs show Tbol caused liver enzyme elevations and long-term hepatic damage in athletes. Dbol shares the same 17-AA modification and carries comparable acute hepatotoxicity risk at equivalent doses.
How long is Tbol detectable vs Dbol?
Tbol's long-chain cysteine metabolite was detectable for many months in WADA anti-doping research, far longer than Dbol metabolites which typically clear within a few weeks by standard urine testing.
Which produces more water retention, Tbol or Dbol?
Dbol causes substantially more water retention because it aromatizes to estrogen, which promotes sodium and water retention via aldosterone pathways. Tbol does not aromatize and produces little to no estrogen-mediated water retention, making strength and weight gains appear leaner.
Can you stack Tbol with Dbol?
Some athletes have stacked them, but layering two 17-alpha-alkylated oral anabolics multiplies hepatotoxic load without a proportional gain in benefit. There is no clinical evidence supporting this combination, and it substantially increases liver injury risk.
Is Tbol or Dbol better for cutting?
Tbol is commonly preferred for cutting contexts because it does not aromatize and causes minimal water retention, so weight changes better reflect lean tissue. Dbol is rarely used for cutting due to the significant fluid gain that obscures body composition changes.
What are the typical doses of Tbol vs Dbol?
East German doping protocols used Tbol at roughly 20-30 mg per day for female athletes and higher for males. Recreational Dbol use typically ranges 25-50 mg per day. Neither compound has an approved medical dosing protocol in the United States today.
Do Tbol and Dbol suppress natural testosterone?
Yes. Both are androgenic anabolic steroids that suppress the hypothalamic-pituitary-gonadal axis via negative feedback, reducing endogenous testosterone production during use. Recovery after cessation varies by dose, duration, and individual.
Are Tbol and Dbol legal?
Both are Schedule III controlled substances in the United States. Neither has a currently approved medical indication in the US. Possession without a valid prescription is a federal criminal offense.
Which compound has more human research behind it?
Dianabol has a longer history of clinical use dating to the 1960s and was studied in clinical trials for osteoporosis and muscle-wasting conditions. Turinabol's human data comes largely from East German state doping records and forensic anti-doping analysis rather than controlled clinical trials.
Sources
- Saartok T, Dahlberg E, Gustafsson JA. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. Endocrinology. 1984;114(6):2100-2106.
- Kochakian CD, ed. Anabolic-Androgenic Steroids. Springer-Verlag, 1976. (Historical reference for anabolic/androgenic ratio data.)
- Thevis M, Schanzer W, et al. Detection of the anabolic steroid turinabol in urine and hair by gas chromatography-mass spectrometry. Drug Testing and Analysis. Published in peer-reviewed anti-doping literature by the German Sport University Cologne group. (Specific DOI not cited to avoid fabrication; refer to PubMed search "Thevis Turinabol" for primary papers.)
- Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clinical Chemistry. 1997;43(7):1262-1279.
- US Drug Enforcement Administration. Controlled Substances Act: Anabolic Steroids, Schedule III. 21 U.S.C. 802(41).
- WADA. World Anti-Doping Code and Prohibited List. Current edition available at wada-ama.org.
- Shahidi NT. A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clinical Therapeutics. 2001;23(9):1355-1390.
- Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Medicine. 2004;34(8):513-554.
Footer Disclaimers
Platform: FormBlends publishes educational content on pharmacology and research compounds. Nothing on this page constitutes medical advice, a treatment recommendation, or encouragement to obtain or use controlled substances.
Research Compound / Legal Status: Turinabol (chlorodehydromethyltestosterone) and Dianabol (methandrostenolone) are Schedule III controlled substances under US federal law. Neither compound has a currently approved New Drug Application (NDA) for medical use in the United States. Acquisition or possession without a valid prescription is a federal criminal offense. Laws vary by jurisdiction; consult local regulations.
Results: Any performance or body composition outcomes described in this article are drawn from historical clinical use or documented doping programs and do not represent typical or expected outcomes. Individual results depend on genetics, diet, training, health status, and other variables.
Trademark: Dianabol is a former registered trademark of Ciba-Geigy. FormBlends has no affiliation with any pharmaceutical manufacturer or underground laboratory producing these compounds. Product names are used for informational identification only.